We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
With effect from 18th January 2019, if you use the SNPCheck service, please point your browsers to its NEW web domain address by visiting the link below.
Samples for the EMQN BRCA Ovarian and NGS Distribution 2019 schemes will be sent on 23/09/2019. Labs will begin to receive these from 24/09/2019 and it may take up to two weeks to physically receive samples depending on your location.
EMQN's scheme catalogue for 2020 is now published and available from the EMQN Home Page. If you have an account you can purchase these, please ensure you fully check out your order to complete the purchase. If you do not have an account, please apply through the EMQN website. Your account will be approved in 24 hours and you can then purchase schemes. Please note the purchase deadline for Germline Scheme is 30/11/2019 and the deadline for Molecular Pathology and Technical Schemes is 28/02/2020
Severe Combined Immunodeficiencies (SCIDs),
Microsatellite Instability (MSI) testing.
See the 2020 EQA scheme catalogue for more information.
Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.
Our 2020 EQA scheme catalogue has been published on the EMQN website. We are looking forward to our colleagues join… https://t.co/bmlachNK56
Validated genotypes published for 2019 Sanger DNA sequencing EQA scheme - log in to your EMQN account to view them. https://t.co/5TqrMUhddC
Validated genotypes published for 2019 molecular pathology EQA schemes - please check your EMQN account. https://t.co/etDM8Uj3kH
FINAL results and certificates for the 2019 germline EQA schemes published - please log in to your EMQN website acc… https://t.co/yPSCenhA4V